Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 15, 2023 Filed Nov 17, 2023 17:03 UTC |
LEPORE PATRICK GDirector
|
PurchaseCommon Stock | 13,000 | $3.91 | $50,778.00 |
DisclosureSEC source: 0001209191-23-055787 · doc4.xml · nonDerivative · entry 1 LEPORE PATRICK G · CIK 0001055404 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,472 F1 · price: The price reported is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $3.57 to $4.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:26 UTC |
Zeronda TylerChief Financial Officer
|
Tax withholdingCommon Stock | 1,087 | $3.83 | $4,163.21 |
DisclosureSEC source: 0001209191-23-051960 · doc4.xml · nonDerivative · entry 1 Zeronda Tyler · CIK 0001867033 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,930 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:23 UTC |
Stuart IainChief Scientific Officer
|
Tax withholdingCommon Stock | 1,184 | $3.83 | $4,534.72 |
DisclosureSEC source: 0001209191-23-051948 · doc4.xml · nonDerivative · entry 1 Stuart Iain · CIK 0001727756 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,055 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:21 UTC |
Harsch MutyaChief Legal Officer and GC
|
Tax withholdingCommon Stock | 1,154 | $3.83 | $4,419.82 |
DisclosureSEC source: 0001209191-23-051944 · doc4.xml · nonDerivative · entry 1 Harsch Mutya · CIK 0001727809 · Chief Legal Officer and GC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,596 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:19 UTC |
Domzalski DavidDirector · President and CEO
|
Tax withholdingCommon Stock | 8,549 | $3.83 | $32,742.67 |
DisclosureSEC source: 0001209191-23-051941 · doc4.xml · nonDerivative · entry 1 Domzalski David · CIK 0001727794 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,884 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 20:37 UTC |
Zeronda TylerChief Financial Officer
|
Tax withholdingCommon Stock | 91 | $4.10 | $373.10 |
DisclosureSEC source: 0001209191-23-041139 · doc4.xml · nonDerivative · entry 1 Zeronda Tyler · CIK 0001867033 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,017 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 20:34 UTC |
Stuart IainChief Scientific Officer
|
Tax withholdingCommon Stock | 151 | $4.10 | $619.10 |
DisclosureSEC source: 0001209191-23-041120 · doc4.xml · nonDerivative · entry 1 Stuart Iain · CIK 0001727756 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,239 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 20:32 UTC |
Harsch MutyaChief Legal Officer and GC
|
Tax withholdingCommon Stock | 157 | $4.10 | $643.70 |
DisclosureSEC source: 0001209191-23-041107 · doc4.xml · nonDerivative · entry 1 Harsch Mutya · CIK 0001727809 · Chief Legal Officer and GC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,750 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 20:30 UTC |
Domzalski DavidDirector · President and CEO
|
Tax withholdingCommon Stock | 981 | $4.10 | $4,022.10 |
DisclosureSEC source: 0001209191-23-041094 · doc4.xml · nonDerivative · entry 1 Domzalski David · CIK 0001727794 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,433 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 20:34 UTC |
Harsch MutyaChief Legal Officer and GC
|
GrantCommon Stock | 3,664 | $3.46 | $12,663.88 |
DisclosureSEC source: 0001209191-23-033802 · doc4.xml · nonDerivative · entry 1 Harsch Mutya · CIK 0001727809 · Chief Legal Officer and GC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,907 F1 · shares: These shares were acquired under the Issuer's Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on December 1, 2022 and ending on May 31, 2023 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's common stock on December 1, 2022. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 20:31 UTC |
Domzalski DavidDirector · President and CEO
|
GrantCommon Stock | 2,766 | $3.46 | $9,560.13 |
DisclosureSEC source: 0001209191-23-033783 · doc4.xml · nonDerivative · entry 1 Domzalski David · CIK 0001727794 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,414 F1 · shares: These shares were acquired under the Issuer's Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on December 1, 2022 and ending on May 31, 2023 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's common stock on December 1, 2022. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 21:07 UTC |
Zeronda TylerChief Financial Officer
|
Tax withholdingCommon Stock | 384 | $3.08 | $1,182.72 |
DisclosureSEC source: 0001209191-23-022806 · doc4.xml · nonDerivative · entry 1 Zeronda Tyler · CIK 0001867033 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,108 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. F2 · balance_after: On February 10, 2023, the Issuer effected a one-for-18 reverse split of its Common Stock. The number of securities reported reflects the reverse split. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 21:05 UTC |
Stuart IainChief Scientific Officer
|
Tax withholdingCommon Stock | 480 | $3.08 | $1,478.40 |
DisclosureSEC source: 0001209191-23-022801 · doc4.xml · nonDerivative · entry 1 Stuart Iain · CIK 0001727756 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,390 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. F2 · balance_after: On February 10, 2023, the Issuer effected a one-for-18 reverse split of its Common Stock. The number of securities reported reflects the reverse split. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 21:03 UTC |
Harsch MutyaChief Legal Officer and GC
|
Tax withholdingCommon Stock | 478 | $3.08 | $1,472.24 |
DisclosureSEC source: 0001209191-23-022798 · doc4.xml · nonDerivative · entry 1 Harsch Mutya · CIK 0001727809 · Chief Legal Officer and GC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,243 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 21:01 UTC |
Domzalski DavidDirector · President and CEO
|
Tax withholdingCommon Stock | 2,734 | $3.08 | $8,420.72 |
DisclosureSEC source: 0001209191-23-022790 · doc4.xml · nonDerivative · entry 1 Domzalski David · CIK 0001727794 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,648 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. F2 · balance_after: On February 10, 2023, the Issuer effected a one-for-18 reverse split of its Common Stock. The number of securities reported reflects the reverse split. Read SEC document |
| March 20, 2023 Filed Mar 22, 2023 16:03 UTC |
LEPORE PATRICK GDirector
|
PurchaseCommon Stock | 20,000 | $2.48 | $49,680.00 |
DisclosureSEC source: 0001209191-23-020480 · doc4.xml · nonDerivative · entry 1 LEPORE PATRICK G · CIK 0001055404 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,472 F1 · price: The price reported is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $2.464 to $2.5199, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: On February 10, 2023, the Issuer effected a one-for-18 reverse split of its Common Stock. The number of securities reported reflects the reverse split. Read SEC document |
| March 20, 2023 Filed Mar 22, 2023 20:01 UTC |
Harsch MutyaChief Legal Officer and GC
|
PurchaseCommon Stock | 10,000 | $2.50 | $25,000.00 |
DisclosureSEC source: 0001209191-23-020477 · doc4.xml · nonDerivative · entry 1 Harsch Mutya · CIK 0001727809 · Chief Legal Officer and GC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,721 F1 · balance_after: On February 10, 2023, the Issuer effected a one-for-18 reverse split of its Common Stock. The number of securities reported reflects the reverse split. Read SEC document |
| December 31, 2022 Filed Jan 4, 2023 22:12 UTC |
Harsch MutyaChief Legal Officer and GC
|
Tax withholdingCommon Stock | 1,813 | $0.15 | $271.95 |
DisclosureSEC source: 0001209191-23-001111 · doc4.xml · nonDerivative · entry 1 Harsch Mutya · CIK 0001727809 · Chief Legal Officer and GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,144 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| December 31, 2022 Filed Jan 4, 2023 22:09 UTC |
Stuart IainChief Scientific Officer
|
Tax withholdingCommon Stock | 1,720 | $0.15 | $258.00 |
DisclosureSEC source: 0001209191-23-001098 · doc4.xml · nonDerivative · entry 1 Stuart Iain · CIK 0001727756 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,252 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| December 31, 2022 Filed Jan 4, 2023 22:03 UTC |
Domzalski DavidDirector · President and CEO
|
Tax withholdingCommon Stock | 10,685 | $0.15 | $1,602.75 |
DisclosureSEC source: 0001209191-23-001066 · doc4.xml · nonDerivative · entry 1 Domzalski David · CIK 0001727794 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,064,290 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| December 31, 2022 Filed Jan 4, 2023 22:05 UTC |
Zeronda TylerChief Financial Officer
|
Tax withholdingCommon Stock | 354 | $0.15 | $53.10 |
DisclosureSEC source: 0001209191-23-001081 · doc4.xml · nonDerivative · entry 1 Zeronda Tyler · CIK 0001867033 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,005 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 21:30 UTC |
Domzalski DavidDirector · President and CEO
|
GrantCommon Stock | 34,705 | $0.20 | $6,861.18 |
DisclosureSEC source: 0001209191-22-059425 · doc4.xml · nonDerivative · entry 1 Domzalski David · CIK 0001727794 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,074,975 F1 · shares: These shares were acquired under the Issuer's Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on June 1, 2022 and ending on November 30, 2022 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's ordinary shares on November 30, 2022 (the last trading day of the offering period). The reporting person purchased the maximum number of shares permitted by the terms of the ESPP during the calendar year. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 21:05 UTC | Tax withholdingCommon Stock | 353 | $0.22 | $78.72 |
DisclosureSEC source: 0001209191-22-052359 · doc4.xml · nonDerivative · entry 1 Zeronda Tyler · CIK 0001867033 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,359 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
|
| September 30, 2022 Filed Oct 4, 2022 21:05 UTC |
Stuart IainChief Scientific Officer
|
Tax withholdingCommon Stock | 1,719 | $0.22 | $383.34 |
DisclosureSEC source: 0001209191-22-052356 · doc4.xml · nonDerivative · entry 1 Stuart Iain · CIK 0001727756 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,972 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 21:04 UTC |
Harsch MutyaChief Legal Officer and GC
|
Tax withholdingCommon Stock | 1,813 | $0.22 | $404.30 |
DisclosureSEC source: 0001209191-22-052353 · doc4.xml · nonDerivative · entry 1 Harsch Mutya · CIK 0001727809 · Chief Legal Officer and GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,957 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 21:00 UTC |
Domzalski DavidDirector · President and CEO
|
Tax withholdingCommon Stock | 10,683 | $0.22 | $2,382.31 |
DisclosureSEC source: 0001209191-22-052350 · doc4.xml · nonDerivative · entry 1 Domzalski David · CIK 0001727794 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,040,270 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 17:11 UTC |
LEPORE PATRICK GDirector
|
GrantStock Options · Derivative | 20,500 | $0.00 Strike: $0.31 | $0.00 |
DisclosureSEC source: 0001209191-22-045651 · doc4.xml · derivative · entry 1 LEPORE PATRICK G · CIK 0001055404 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,500 Underlying: Common Stock · 20,500 shares Expires 2032-08-10 F1 · derivative.exercise_date: Represents the annual award to non-executive directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. These options vest over a 12-month period in equal, monthly installments, ending August 10, 2023. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 17:10 UTC |
Basta Steven LDirector
|
GrantStock Options · Derivative | 20,500 | $0.00 Strike: $0.31 | $0.00 |
DisclosureSEC source: 0001209191-22-045649 · doc4.xml · derivative · entry 1 Basta Steven L · CIK 0001417397 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,500 Underlying: Common Stock · 20,500 shares Expires 2032-08-10 F1 · derivative.exercise_date: Represents the annual award to non-executive directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. These options vest over a 12-month period in equal, monthly installments, ending August 10, 2023. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 17:11 UTC |
Bruno Anthony DDirector
|
GrantStock Options · Derivative | 20,500 | $0.00 Strike: $0.31 | $0.00 |
DisclosureSEC source: 0001209191-22-045650 · doc4.xml · derivative · entry 1 Bruno Anthony D · CIK 0001374180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,500 Underlying: Common Stock · 20,500 shares Expires 2032-08-10 F1 · derivative.exercise_date: Represents the annual award to non-executive directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. These options vest over a 12-month period in equal, monthly installments, ending August 10, 2023. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 17:10 UTC |
BARBARI SHARONDirector
|
GrantStock Options · Derivative | 20,500 | $0.00 Strike: $0.31 | $0.00 |
DisclosureSEC source: 0001209191-22-045648 · doc4.xml · derivative · entry 1 BARBARI SHARON · CIK 0001240499 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,500 Underlying: Common Stock · 20,500 shares Expires 2032-08-10 F1 · derivative.exercise_date: Represents the annual award to non-executive directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. These options vest over a 12-month period in equal, monthly installments, ending August 10, 2023. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 21:12 UTC |
Little Elisabeth SandovalDirector
|
GrantStock Options · Derivative | 20,500 | $0.00 Strike: $0.31 | $0.00 |
DisclosureSEC source: 0001209191-22-045653 · doc4.xml · derivative · entry 1 Sandoval Elisabeth · CIK 0001632295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,500 Underlying: Common Stock · 20,500 shares Expires 2032-08-10 F1 · derivative.exercise_date: Represents the annual award to non-executive directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. These options vest over a 12-month period in equal, monthly installments, ending August 10, 2023. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 21:01 UTC | Tax withholdingCommon Stock | 354 | $0.39 | $137.71 |
DisclosureSEC source: 0001209191-22-040789 · doc4.xml · nonDerivative · entry 1 Zeronda Tyler · CIK 0001867033 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,712 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
|
| June 30, 2022 Filed Jul 5, 2022 21:01 UTC |
Stuart IainChief Scientific Officer
|
Tax withholdingCommon Stock | 1,719 | $0.39 | $668.69 |
DisclosureSEC source: 0001209191-22-040788 · doc4.xml · nonDerivative · entry 1 Stuart Iain · CIK 0001727756 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,691 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 21:00 UTC |
Harsch MutyaChief Legal Officer and GC
|
Tax withholdingCommon Stock | 1,813 | $0.39 | $705.26 |
DisclosureSEC source: 0001209191-22-040783 · doc4.xml · nonDerivative · entry 1 Harsch Mutya · CIK 0001727809 · Chief Legal Officer and GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,770 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 21:00 UTC |
Domzalski DavidDirector · President and CEO
|
Tax withholdingCommon Stock | 10,683 | $0.39 | $4,155.69 |
DisclosureSEC source: 0001209191-22-040778 · doc4.xml · nonDerivative · entry 1 Domzalski David · CIK 0001727794 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,050,953 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 20:35 UTC |
Domzalski DavidDirector · President and CEO
|
GrantCommon Stock | 11,887 | $0.35 | $4,116.47 |
DisclosureSEC source: 0001209191-22-033542 · doc4.xml · nonDerivative · entry 1 Domzalski David · CIK 0001727794 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,061,636 F1 · shares: These shares were acquired under the Issuer's Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on December 1, 2021 and ending on May 31, 2022 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's common stock on May 31, 2022 (the last trading day of the offering period). Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 20:36 UTC | GrantCommon Stock | 12,510 | $0.35 | $4,332.21 |
DisclosureSEC source: 0001209191-22-033544 · doc4.xml · nonDerivative · entry 1 Zeronda Tyler · CIK 0001867033 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,066 F1 · shares: These shares were acquired under the Issuer's Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on December 1, 2021 and ending on May 31, 2022 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's common stock on May 31, 2022 (the last trading day of the offering period). Read SEC document |
|
| March 31, 2022 Filed Apr 4, 2022 21:10 UTC | Tax withholdingCommon Stock | 773 | $0.65 | $502.45 |
DisclosureSEC source: 0001209191-22-022532 · doc4.xml · nonDerivative · entry 1 Zeronda Tyler · CIK 0001867033 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,556 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
|
| March 31, 2022 Filed Apr 4, 2022 21:09 UTC |
Stuart IainChief Scientific Officer
|
Tax withholdingCommon Stock | 3,469 | $0.65 | $2,254.85 |
DisclosureSEC source: 0001209191-22-022530 · doc4.xml · nonDerivative · entry 1 Stuart Iain · CIK 0001727756 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,410 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 21:09 UTC |
Harsch MutyaChief Legal Officer and GC
|
Tax withholdingCommon Stock | 3,630 | $0.65 | $2,359.50 |
DisclosureSEC source: 0001209191-22-022526 · doc4.xml · nonDerivative · entry 1 Harsch Mutya · CIK 0001727809 · Chief Legal Officer and GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,583 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 21:08 UTC |
Domzalski DavidDirector · President and CEO
|
Tax withholdingCommon Stock | 23,186 | $0.65 | $15,070.90 |
DisclosureSEC source: 0001209191-22-022523 · doc4.xml · nonDerivative · entry 1 Domzalski David · CIK 0001727794 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,049,749 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| March 17, 2022 Filed Mar 18, 2022 21:10 UTC | GrantStock Options · Derivative | 75,000 | $0.00 Strike: $0.61 | $0.00 |
DisclosureSEC source: 0001209191-22-020067 · doc4.xml · derivative · entry 2 Zeronda Tyler · CIK 0001867033 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2032-03-17 F2 · derivative.exercise_date: The awards vest over four years, 25% on March 31, 2023 and 6.25% every three months thereafter, ending on March 31, 2026. Read SEC document |
|
| March 17, 2022 Filed Mar 18, 2022 21:10 UTC | GrantCommon Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-020067 · doc4.xml · nonDerivative · entry 1 Zeronda Tyler · CIK 0001867033 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,329 F1 · shares: Represents restricted stock unit awards, each of which by its terms represents a contingent right to receive one share of common stock of VYNE Therapeutics Inc. Read SEC document |
|
| March 17, 2022 Filed Mar 18, 2022 21:10 UTC |
Stuart IainChief Scientific Officer
|
GrantStock Options · Derivative | 75,000 | $0.00 Strike: $0.61 | $0.00 |
DisclosureSEC source: 0001209191-22-020066 · doc4.xml · derivative · entry 2 Stuart Iain · CIK 0001727756 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2032-03-17 F2 · derivative.exercise_date: The awards vest over four years, 25% on March 31, 2023 and 6.25% every three months thereafter, ending on March 31, 2026. Read SEC document |
| March 17, 2022 Filed Mar 18, 2022 21:10 UTC |
Stuart IainChief Scientific Officer
|
GrantCommon Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-020066 · doc4.xml · nonDerivative · entry 1 Stuart Iain · CIK 0001727756 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 228,879 F1 · shares: Represents restricted stock unit awards, each of which by its terms represents a contingent right to receive one share of common stock of VYNE Therapeutics Inc. Read SEC document |
| March 17, 2022 Filed Mar 18, 2022 21:09 UTC |
Harsch MutyaChief Legal Officer and GC
|
GrantStock Options · Derivative | 75,000 | $0.00 Strike: $0.61 | $0.00 |
DisclosureSEC source: 0001209191-22-020065 · doc4.xml · derivative · entry 2 Harsch Mutya · CIK 0001727809 · Chief Legal Officer and GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2032-03-17 F2 · derivative.exercise_date: The awards vest over four years, 25% on March 31, 2023 and 6.25% every three months thereafter, ending on March 31, 2026. Read SEC document |
| March 17, 2022 Filed Mar 18, 2022 21:09 UTC |
Harsch MutyaChief Legal Officer and GC
|
GrantCommon Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-020065 · doc4.xml · nonDerivative · entry 1 Harsch Mutya · CIK 0001727809 · Chief Legal Officer and GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,213 F1 · shares: Represents restricted stock unit awards, each of which by its terms represents a contingent right to receive one share of common stock of VYNE Therapeutics Inc. Read SEC document |
| March 17, 2022 Filed Mar 18, 2022 21:09 UTC |
Domzalski DavidDirector · President and CEO
|
GrantStock Options · Derivative | 312,303 | $0.00 Strike: $0.61 | $0.00 |
DisclosureSEC source: 0001209191-22-020064 · doc4.xml · derivative · entry 2 Domzalski David · CIK 0001727794 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312,303 Underlying: Common Stock · 312,303 shares Expires 2032-03-17 F2 · derivative.exercise_date: The awards vest over four years, 25% on March 31, 2023 and 6.25% every three months thereafter, ending on March 31, 2026. Read SEC document |
| March 17, 2022 Filed Mar 18, 2022 21:09 UTC |
Domzalski DavidDirector · President and CEO
|
GrantCommon Stock | 312,302 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-020064 · doc4.xml · nonDerivative · entry 1 Domzalski David · CIK 0001727794 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,072,935 F1 · shares: Represents restricted stock unit awards, each of which by its terms represents a contingent right to receive one share of common stock of VYNE Therapeutics Inc. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 21:40 UTC |
Zeronda TylerInterim CFO
|
Tax withholdingCommon Stock | 206 | $1.02 | $210.12 |
DisclosureSEC source: 0001209191-22-000861 · doc4.xml · nonDerivative · entry 1 Zeronda Tyler · CIK 0001867033 · Interim CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,329 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.